Accordingly, as shown herein, elicitation of flagellin-specific IgA via exogenous administration of flagellin has potential to protect against some chronic inflammatory diseases, including colitis and obesity. This evidence concerns the gene CD79A and obesity due to melanocortin 4 receptor deficiency.